We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

7 hedge funds and large institutions have $3.91M invested in Stealth BioTherapeutics Corp. ADS in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KCM
Kingdon Capital Management
New York
+$2.4M
2
Millennium Management
Millennium Management
New York
+$698K
3
DIM
DC Investments Management
Virginia
+$678K
4
Bank of America
Bank of America
North Carolina
+$325K
5
CCA
Catalyst Capital Advisors
New York
+$7.64K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Kingdon Capital Management
New York
$2.28M +$2.4M +178,453 New
Millennium Management
2
Millennium Management
New York
$666K +$698K +51,928 New
DIM
3
DC Investments Management
Virginia
$646K +$678K +50,420 New
Bank of America
4
Bank of America
North Carolina
$310K +$325K +24,190 New
CCA
5
Catalyst Capital Advisors
New York
$7K +$7.64K +568 New
UBS Group
6
UBS Group
Switzerland
$1K +$874 +65 New
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
– +$40 +3 New

MITO Hedge Fund Activity: Q1 2019 in Review

7 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q1 2019, worth a combined $3.91M.

Buyers outnumbered sellers: 7 funds opened new MITO positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Kingdon Capital Management, opening a new position worth an estimated $2.4M.

  • 7 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q1 2019, up from 0 in Q4 2018.
  • Funds reported $3.91M of Stealth BioTherapeutics Corp. ADS stock for Q1 2019.
  • 7 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q1 2019 and 0 closed out, a net change of +7 holders.
  • The largest Stealth BioTherapeutics Corp. ADS buyer in Q1 2019 was Kingdon Capital Management, an estimated $2.4M added.

Based on aggregated 13F filings for Q1 2019.